Detection and typification of human papilloma virus in pre cancerous cervical lesions;Detección y tipificación de virus papiloma humano en lesiones preneoplásicas del cuello uterino mediante PCR-RFLP

Revista Medica de Chile

Volumn 135, Issue 2, 2007, Pages 167-173

  Aedo A, Susana ^a   Melo A, Angélica ^a   García, Patricia ^a   Guzmán G, Pablo ^a   Capurro V, Italo ^b   Roa S, Juan Carlos ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

Human papilloma virus; Oncogenes; Uterine cervical cancer

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CLASSIFICATION; DNA PROBE; FEMALE; GENETICS; GENOTYPE; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PRECANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33947592218     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Serra I SL, Castro R, García V, Serra J, Desinti E, Cárcamo S. Cáncer cervicouterino, un desafío sin resolver. Rev Chil Obstet Ginecol 1997; 62: 75-85.
2. Ponten J, Guo Z. Precancer of the human cervix. Cancer Surv 1998; 32: 201-29.
3. Koopman LA, Szuhai K, van Eendenburg JD, Bezrookove V, Kenter GG, Schuuring E et al. Recurrent integration of human papilloma viruses 16, 45, and 67 translocation breakpoints in new cervical cancer cell lines. Cancer Res 1999; 59: 5615-24.
4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al. Prevalence of human papilloma virus in cervical cancer: a perspective. International biological study on cervical cancer Study Group. J Natl Cancer Inst 1995; 87: 796-802.
5. Munoz N, Bosch FX. The causal link between HPV and cervical cancer and its prevention of cervical cancer. Bull Pan Am Health Organ 1996; 30: 362-77.
6. Villa LL, Franco EL. Epidemiologic correlates of cervical neoplasia and risk of human papilloma virus infection in asymptomatic women in Brazil. J Natl Cancer Inst 1989; 81: 332-40.
7. Melo A, Montenegro S, Hooper T, Capurro I, Roa JC, Roa I. [Human papilloma virus (HPV) typing in preneoplastic and lesions of the uterine cervix in the IX region-Chile]. Rev Méd Chile 2003; 131: 1382-90.
8. Melo A, Montenegro S, Roa I, Capurro I, Roa JC. Estudio comparativo de detección del virus papiloma humano (HPV) en muestras citológicas y biopsias de cuello uterino. Rev Méd Chile 2005; 133: 639-44.
9. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al. Epidemiologic classification of human papilloma virus types cervical cancer. N Engl J Med 2003; 348: 518-27.
10. Villa LL. Human papilloma viruses and cervical cancer. Adv Cancer Res 1997; 71: 321-41.
11. Sasagawa T, Dong Y, Saijoh K, Satake S, Tateno M, Inoue M. Human papilloma virus infection and risk determinants for intraepithelial lesion and cervical cancer in Japan. Jpn J Cancer Res 1997; 88: 376-84.
12. Jenkins D. Diagnosing human papilloma viruses: recent advances. Curr Opin Infect Dis 2001; 14: 53-62.
13. Ronco G. [Use of molecular tests of human papilloma virus (HPV) as for cervix cancer: a review]. Epidemiol Prev 1999; 23: 372-7.
14. Lorincz AT, Richart RM. Human papilloma virus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003; 127: 959-68.
15. Manos MM TY, Wright DK, Lewis A, Broker T, Wolinsky S. Use of polymerase chain reaction amplification for the detection of genital human papilloma viruses. Cancer Cells 1989; 7: 209-14.
16. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fujinaga K. Simultaneous detection and typing of genital human using the polymerase chain reaction. J Gen Virol 1991; 72: 1039-44.
17. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction detection of a broad spectrum of human papilloma virus genotypes. J Gen Virol 1990; 71: 173-81.
18. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ adjacent highly conserved sequences improves human detection by PCR. J Gen Virol 1995; 76: 1057-62.
19. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J et al. Detection and typing of human papilloma virus in archival specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-84.
20. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two of oligonucleotide probes. J Clin Microbiol 1995; 33: 901-5.
21. Socias M GJ, Figueroa J, Fernández F. Perfil epidemiológico y clínico de la tipificación del HPV captura híbrida, método DIGENE. Rev Chil Obstet Ginecol 1997; 62: 167-73.
22. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ et al. Population-based prevalence and age distribution of human papilloma virus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004; 13: 2271-6.
23. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL et al. Human papilloma virus infection at the United States-Mexico implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001; 10: 1129-36.
24. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P et al. Epidemiology of HPV infection among Mexican women with normal cytology. Int J Cancer 2001; 91: 412-20.
25. Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M et al. HPV prevalence among Mexican women with neoplastic and normal. Gynecol Oncol 1998; 70: 115-20.
26. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM et al. Human papilloma virus infection, cervical dysplasia and invasive cancer in Honduras: a case-control study. Int J Cancer 1999; 82: 799-803.
27. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M et al. Epidemiology of acquisition and clearance of cervical human infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180: 1415-23.
28. Serrano ML CM, Medina O, Melgarejo D, Bravo MM. Tipificación del virus papiloma humano mediante secuencia directa en mujeres con citología normal. Revista Colombiana de Cancerología 2003; 7: 18-24.
29. van Doorn LJ, Quint W, Kleter B, Molijn A, Colau B, Martin MT et al. Genotyping of human papilloma virus in liquid cytology cervical by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 2002; 40: 979-83.
30. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papilloma virus types in invasive cervical cancer meta-analysis. Br J Cancer 2003; 88: 63-73.
31. Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R et al. Human papilloma virus types 52 and 58 are prevalent in cervical Chinese women. Int J Cancer 1997; 73: 775-6.
32. Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papilloma virus infections cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 45-52.
33. Vernon SD, Unger ER, Williams D. Comparison of human papilloma virus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000; 38: 651-5.
34. Gharizadeh B, Kalantari M, García CA, Johansson B, Nyren P. Typing of human papilloma virus by pyrosequencing. Lab Invest 2001; 81: 673-9.
35. Melchers W, van den Brule A, Walboomers J, de Bruin M, Burger M, Herbrink P et al. Increased detection rate of human papilloma virus in cervical the polymerase chain reaction as compared to modified FISH and southern-blot analysis. J Med Virol 1989; 27: 329-35.
36. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papilloma virus infection in. N Engl J Med 1998; 338: 423-8.
37. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P et al. Persistent genital human papilloma virus infection as a risk persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
38. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papilloma virus and cervical. J Clin Pathol 2002; 55: 244-65.
39. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N et al. Detection and typing of human papilloma virus by e6 nested. J Clin Microbiol 2004; 42: 3176-84.
40. Evander M, Edlund K, Boden E, Gustafsson A, Jonsson M, Karlsson R et al. Comparison of a one-step and a two-step polymerase chain degenerate general primers in a population-based study of human papilloma virus infection in young Swedish women. J Clin Microbiol 1992; 30: 987-92.
41. Husnjak K, Grce M, Magdic L, Pavelic K. Comparison of five different polymerase chain reaction methods detection of human papilloma virus in cervical cell specimens. J Virol Methods 2000; 88: 125-34.